(Q40156193)

18 September 2017

title

An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo (English)

1 reference

18 September 2017

1 reference

1 reference

Jianmin Fang

1

1 reference

18 September 2017

Saili Yi

2

1 reference

18 September 2017

Andrew Simmons

3

1 reference

18 September 2017

Guang Huan Tu

4

1 reference

18 September 2017

Minh Nguyen

5

1 reference

18 September 2017

Thomas C Harding

6

1 reference

18 September 2017

Melinda VanRoey

7

1 reference

18 September 2017

Karin Jooss

8

1 reference

18 September 2017

publication date

20 March 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

15

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

1153-1159

1 reference

Stable antibody expression at therapeutic levels using the 2A peptide

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Therapeutic antibody gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Immunotherapy made more accessible?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

A humanized system for pharmacologic control of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Furin proteolytically processes the heparin-binding region of extracellular superoxide dismutase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

1 reference

7 January 2021

Characterization of humanized anti-TAC, an antibody directed against the interleukin 2 receptor, using electrospray ionization mass spectrometry by direct infusion, LC/MS, and MS/MS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Therapeutic antibody gene transfer: an active approach to passive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Monoclonal antibody therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300142

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300142

1 reference

18 September 2017

1 reference